SG158015A1 - New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- SG158015A1 SG158015A1 SG200903642-7A SG2009036427A SG158015A1 SG 158015 A1 SG158015 A1 SG 158015A1 SG 2009036427 A SG2009036427 A SG 2009036427A SG 158015 A1 SG158015 A1 SG 158015A1
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- compositions containing
- pharmaceutical compositions
- azabicyclic compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0803297A FR2932479A1 (fr) | 2008-06-13 | 2008-06-13 | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
SG158015A1 true SG158015A1 (en) | 2010-01-29 |
Family
ID=40227963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200903642-7A SG158015A1 (en) | 2008-06-13 | 2009-05-29 | New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (29)
Country | Link |
---|---|
US (1) | US7906547B2 (es) |
EP (1) | EP2133333A1 (es) |
JP (1) | JP2009298790A (es) |
KR (1) | KR20090129958A (es) |
CN (1) | CN101602706A (es) |
AP (1) | AP2009004891A0 (es) |
AR (1) | AR072101A1 (es) |
AU (1) | AU2009202341A1 (es) |
BR (1) | BRPI0902395A2 (es) |
CA (1) | CA2668527A1 (es) |
CL (1) | CL2009001377A1 (es) |
CO (1) | CO6190096A1 (es) |
CR (1) | CR10844A (es) |
EA (1) | EA200900692A1 (es) |
EC (1) | ECSP099396A (es) |
FR (1) | FR2932479A1 (es) |
GT (1) | GT200900150A (es) |
MA (1) | MA31141B1 (es) |
MX (1) | MX2009005891A (es) |
MY (1) | MY144748A (es) |
NI (1) | NI200900114A (es) |
NZ (1) | NZ577438A (es) |
PE (1) | PE20091961A1 (es) |
SG (1) | SG158015A1 (es) |
SV (1) | SV2009003292A (es) |
TW (1) | TW201000101A (es) |
UY (1) | UY31857A1 (es) |
WO (1) | WO2009150331A1 (es) |
ZA (1) | ZA200903939B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10892398B2 (en) * | 2019-03-28 | 2021-01-12 | Johannes Pollanen | Qubit hardware for electrons on helium |
EP4251148A1 (en) | 2020-11-27 | 2023-10-04 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515013B2 (en) * | 2000-07-13 | 2003-02-04 | Abbott Laboratories | 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
JP2006518707A (ja) * | 2002-12-10 | 2006-08-17 | ランバクシー ラボラトリーズ リミテッド | ムスカリン様受容体アンタゴニストとしての3,6−二置換アザビシクロ[3.1.0]ヘキサン誘導体 |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1707203A1 (en) * | 2005-04-01 | 2006-10-04 | Bioprojet | Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands |
CN101189228A (zh) * | 2005-04-08 | 2008-05-28 | 辉瑞产品有限公司 | 用作i型甘氨酸转运抑制剂的二环[3.1.0]杂芳酰胺 |
EP1842846A1 (en) * | 2006-04-07 | 2007-10-10 | Santhera Pharmaceuticals (Schweiz) AG | Phenylpiperidine derivatives as melanocortin-4 receptor modulators |
GB2454615A (en) * | 2006-07-21 | 2009-05-13 | Lupin Ltd | Antidiabetic azabicyclo (3.1.0) hexan compounds |
-
2008
- 2008-06-13 FR FR0803297A patent/FR2932479A1/fr not_active Withdrawn
-
2009
- 2009-05-29 SG SG200903642-7A patent/SG158015A1/en unknown
- 2009-05-29 UY UY031857A patent/UY31857A1/es not_active Application Discontinuation
- 2009-06-01 PE PE2009000758A patent/PE20091961A1/es not_active Application Discontinuation
- 2009-06-03 GT GT200900150A patent/GT200900150A/es unknown
- 2009-06-03 MY MYPI20092264A patent/MY144748A/en unknown
- 2009-06-04 NZ NZ577438A patent/NZ577438A/en not_active IP Right Cessation
- 2009-06-04 MX MX2009005891A patent/MX2009005891A/es not_active Application Discontinuation
- 2009-06-05 ZA ZA200903939A patent/ZA200903939B/en unknown
- 2009-06-08 CR CR10844A patent/CR10844A/es not_active Application Discontinuation
- 2009-06-08 AP AP2009004891A patent/AP2009004891A0/xx unknown
- 2009-06-08 CL CL2009001377A patent/CL2009001377A1/es unknown
- 2009-06-09 EC EC2009009396A patent/ECSP099396A/es unknown
- 2009-06-09 NI NI200900114A patent/NI200900114A/es unknown
- 2009-06-10 SV SV2009003292A patent/SV2009003292A/es unknown
- 2009-06-10 AU AU2009202341A patent/AU2009202341A1/en not_active Abandoned
- 2009-06-11 WO PCT/FR2009/000696 patent/WO2009150331A1/fr active Application Filing
- 2009-06-11 EP EP09290432A patent/EP2133333A1/fr not_active Withdrawn
- 2009-06-11 EA EA200900692A patent/EA200900692A1/ru unknown
- 2009-06-11 AR ARP090102108A patent/AR072101A1/es unknown
- 2009-06-12 JP JP2009140660A patent/JP2009298790A/ja not_active Withdrawn
- 2009-06-12 US US12/456,165 patent/US7906547B2/en not_active Expired - Fee Related
- 2009-06-12 CO CO09061577A patent/CO6190096A1/es not_active Application Discontinuation
- 2009-06-12 TW TW098119836A patent/TW201000101A/zh unknown
- 2009-06-12 CA CA002668527A patent/CA2668527A1/fr not_active Abandoned
- 2009-06-12 KR KR1020090052291A patent/KR20090129958A/ko not_active Application Discontinuation
- 2009-06-12 MA MA31986A patent/MA31141B1/fr unknown
- 2009-06-15 BR BRPI0902395-0A patent/BRPI0902395A2/pt not_active Application Discontinuation
- 2009-06-15 CN CNA2009101459752A patent/CN101602706A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
BRPI0902395A2 (pt) | 2010-04-20 |
US20090312389A1 (en) | 2009-12-17 |
MX2009005891A (es) | 2010-02-17 |
ZA200903939B (en) | 2010-04-28 |
MA31141B1 (fr) | 2010-02-01 |
KR20090129958A (ko) | 2009-12-17 |
AR072101A1 (es) | 2010-08-04 |
AP2009004891A0 (en) | 2009-06-30 |
UY31857A1 (es) | 2009-08-31 |
CO6190096A1 (es) | 2010-08-19 |
WO2009150331A1 (fr) | 2009-12-17 |
PE20091961A1 (es) | 2010-01-23 |
NI200900114A (es) | 2010-02-03 |
CL2009001377A1 (es) | 2010-05-28 |
CN101602706A (zh) | 2009-12-16 |
NZ577438A (en) | 2010-09-30 |
US7906547B2 (en) | 2011-03-15 |
EA200900692A1 (ru) | 2009-12-30 |
CR10844A (es) | 2009-07-23 |
EP2133333A1 (fr) | 2009-12-16 |
FR2932479A1 (fr) | 2009-12-18 |
TW201000101A (en) | 2010-01-01 |
GT200900150A (es) | 2011-08-25 |
ECSP099396A (es) | 2010-01-29 |
JP2009298790A (ja) | 2009-12-24 |
MY144748A (en) | 2011-10-31 |
AU2009202341A1 (en) | 2010-01-07 |
CA2668527A1 (fr) | 2009-12-13 |
SV2009003292A (es) | 2010-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
TW200745084A (en) | Novel compounds | |
TW200745067A (en) | Novel compounds | |
MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
TW200616995A (en) | Novel compounds | |
MX2009005461A (es) | N-oxidos de analogos de 4,5-epoxi-morfinano. | |
TW200800999A (en) | Novel compounds | |
JO2673B1 (en) | Diosmetin compounds, method of preparation and pharmaceutical compositions | |
TW200745114A (en) | Novel compounds | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
TW200801003A (en) | Novel compounds | |
TW200738659A (en) | Novel compounds | |
TW200635917A (en) | Novel compounds | |
MX2009005048A (es) | Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. | |
TW200800967A (en) | Benzimidazole thiophene compounds | |
MY150497A (en) | New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them | |
TW200635916A (en) | Compounds | |
TW200605888A (en) | Novel compounds | |
JO2616B1 (ar) | مركبات ثلاثية الحلقات جديدة، طريقة من أجل تحضيرها ومركباتها الصيدلانية | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
TW200833371A (en) | Process for solid formulations | |
MX2009008221A (es) | Antagonista de receptor de cromeno s1p1. | |
TW200722418A (en) | Novel compounds | |
GEP20084503B (en) | New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |